GENEVA (Reuters) - The World Health Organization needs to see clinical data and information of good manufacturing practice to be able to evaluate Russia's Sputnik V coronavirus vaccine, WHO assistant director general Mariangela Simao said on Friday.
Russia’s Sputnik V vaccine is more than 90% effective, a representative of the health ministry said this month, citing data collated from vaccinations of the public rather than from an ongoing trial.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!